International Dermatology Outcome Measures (IDEOM) - Report from the 2022 Annual Meeting.
| Publication Type | Conference Paper |
| Authors | Lee K, Woodbury M, Zundell M, Aguero R, Yousif J, Williams S, Rosmarin D, Silverberg N, Thiboutot D, Larocca C, Shinohara M, Mostaghimi A, Stander S, Martorell A, Jaleel T, Torbeck R, Siegel D, Perez-Chada L, Strand V, Armstrong A, Merola J, Gottlieb A |
| Journal | J Drugs Dermatol |
| Volume | 22 |
| Issue | 12 |
| Pagination | 1153-1159 |
| Date Published | 12/01/2023 |
| ISSN | 1545-9616 |
| Keywords | Alopecia Areata, Dermatology, Psoriasis, Skin Neoplasms |
| Abstract | BACKGROUND: The International Dermatology Outcome Measures (IDEOM) is a non-profit organization dedicated to the advancement of evidence-based, consensus-driven outcome measures in dermatological diseases. Researchers and stakeholders from various backgrounds collaborate to develop these objective benchmark metrics to further advance treatment and management of dermatological conditions. SUMMARY: The 2022 IDEOM Annual Meeting was held on June 17-18, 2022. Leaders and stakeholders from the hidradenitis suppurativa, acne, vitiligo, actinic keratosis, alopecia areata, itch, cutaneous lymphoma, and psoriatic disease workgroups discussed the progress of their respective outcome-measures research. This report summarizes each workgroup's updates from 2022 and their next steps as established during the 2022 IDEOM Annual Meeting. J Drugs Dermatol. 2023;22(12):1153-1159 doi:10.36849/JDD.7615. |
| DOI | 10.36849/JDD.7615 |
| PubMed ID | 38051841 |